Journal of Psychosocial Nursing and Mental Health Services

Clip & Save Drug Chart 

FDA-Approved Drugs to Treat ADHD

Abstract

Table

Table

A handy source of up-to-date information on current medications for psychiatric illnesses

Generic NameBrand NameIndications/ApprovalsContraindicationsPrecautions
AmphetamineAdzenys ER®Adzenys XR®Ages 6 and olderConcomitant use of MAOI drugsDrug abuse/dependence; sudden death (avoid in patients with serious cardiac conditions); hypertension; tachycardia; mania; psychosis; growth suppression; weight loss
Dyanavel XR®Ages 6 and olderConcomitant use of MAOI drugsDrug abuse/dependence; sudden death (avoid in patients with serious cardiac conditions); hypertension; tachycardia; mania; psychosis; growth suppression; weight loss
Evekeo®Ages 3 and olderConcomitant use of MAOI drugsDrug abuse/dependence; sudden death (avoid in patients with serious cardiac conditions); hypertension; tachycardia; mania; psychosis; growth suppression; weight loss
Atomoxetine HClStrattera®Ages 6 and older (not approved for geriatric use)Narrow-angle glaucoma; monoamine oxidase inhibitors (MAOIs); hepatic impairment; hypersensitivity to atomoxetine or its constituentsSudden death (avoid in patients with serious cardiac conditions); hypertension and other cardiovascular conditions; psychosis; suicidal ideation; severe liver injury; priapism (in men); allergies
BupropionWellbutrin®Wellbutrin SR®Wellbutrin XR®Ages 12 and olderHypersensitivity to bupropion or any component; MAOI use within 14 days; abrupt alcohol, benzodiazepine, sedative, or antiepileptic discontinuation; seizure disorderSuicidal ideation; arteriovenous malformation; drug or alcohol abuse; lowered seizure threshold; renal or haptic impairment; older adults
Clonidine HClKapvay®Ages 6 to 17Hypersensitivity to clonidine or to any component of the productDry mouth; orthostatic hypotension; syncope; somnolence; fatigue; dizziness; headache; risk of rebound hypertension with abrupt withdrawal; risk of decreased blood pressure and decreased heart rate in patients with history of cardiovascular disease, bradycardia, heart block, or hypotension
DexmethylphenidateFocalin®Focalin XR®Ages 6 and olderHypersensitivity to methylphenidate; glaucoma; tics or family or personal history of Tourette's syndrome; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiac conditions); hypertension and other cardiovascular conditions; psychosis; depression; seizures; visual disturbance; drug abuse or dependence; priapism (in men)
Dextroamphetamine sulfateDexedrine®Ages 3 to 16Advanced arteriosclerosis; symptomatic cardiovascular disease; moderate-to-severe hypertension; hyperthyroidism; known hypersensitivity or idiosyncrasy to sympathomimetic amines; glaucoma; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiac conditions); hypertension and other cardiovascular conditions; psychosis; depression; seizures; visual disturbance; drug abuse or dependence
GuanfacineIntuniv®Ages 6 to 17Hypersensitivity to guanfacine or to any component of the productDry mouth; orthostatic hypotension; syncope; somnolence; fatigue; dizziness; headache; risk of rebound hypertension with abrupt withdrawal; risk of decreased blood pressure and decreased heart rate in patients with history of cardiovascular disease, bradycardia, heart block, or hypotension
Lisdexamfetamine dimesylateVyvanse®Ages 6 and olderAdvanced arteriosclerosis; symptomatic cardiovascular disease; moderate-to-severe hypertension; hyperthyroidism; known hypersensitivity or idiosyncrasy to sympathomimetic amines; glaucoma; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiac conditions); hypertension and other cardiovascular conditions; psychosis; seizures; visual disturbance; drug abuse or dependence
Methylphenidate HClAdhansia XR®Aptensio XR®Ages 6 and olderHypersensitivity to methylphenidate; MAOI use within 14 daysSudden death (avoid in patients with serious cardiac conditions); hypertension and other cardiovascular conditions; psychosis; drug abuse or dependence; peripheral vasculopathy; long-term suppression of growth; priapism (in men)
Methylphenidate HClConcerta®Ages 6 to 65Hypersensitivity to methylphenidate; glaucoma; hypertension; tics or family or personal history of Tourette's syndrome; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiacconditions); hypertension and other cardiovascular conditions; psychosis; depression; seizures; potential for gastrointestinal obstruction; visual disturbance; drug abuse or dependence; priapism (in men)
Cotempla XR-ODT®Ages 6 to 17Hypersensitivity to methylphenidate; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiacconditions); hypertension and other cardiovascular conditions; circulation problems; psychosis; depression; drug abuse or dependence; priapism (in men)
Daytrana (transdermal patch)Ages 6 to 17Hypersensitivity to methylphenidate; glaucoma; tics or family or personal history of Tourette's syndrome; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiacconditions); hypertension and other cardiovascular conditions; psychosis; depression; seizures; visual disturbance; drug abuse or dependence; contact sensitization
Jornay PMAges 6 and olderHypersensitivity to methylphenidate; MAOIsSudden death (avoid in patients with serious cardiacconditions); hypertension and other cardiovascular conditions; psychosis; drug abuse or dependence; peripheral vasculopathy; long-term suppression of growth; priapism (in men)
Metadate CD®Metadate ER®Ages 6 to 15Hypersensitivity to methylphenidate; hypertension; glaucoma; tics or family or personal history of Tourette's syndrome; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiacconditions); hypertension and other cardiovascular conditions; psychosis; depression; seizures; visual disturbance; drug abuse or dependence
Methylin®Ages 6 and olderHypersensitivity to methylphenidate; glaucoma; tics or family or personal history of Tourette's syndrome; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiacconditions); hypertension and other cardiovascular conditions; psychosis; depression; seizures; visual disturbance; drug abuse or dependence
Quillichew ER®Ages 6 and olderHypersensitivity to methylphenidate; glaucoma; hypertension; tics or family or personal history of Tourette's syndrome; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiacconditions); hypertension and other cardiovascular conditions; psychosis; depression; seizures; visual disturbance; drug abuse or dependence
Quillivant XR®Ages 6 to 12Hypersensitivity to methylphenidate; glaucoma; hypertension; tics or family or personal history of Tourette's syndrome; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiacconditions); hypertension and other cardiovascular conditions; psychosis; depression; seizures; visual disturbance; drug abuse or dependence
Ritalin®Ritalin LA®Ritalin SR®Ages 6 to 12Hypersensitivity to methylphenidate; glaucoma; tics or family or personal history of Tourette's syndrome; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiacconditions); hypertension and other cardiovascular conditions; psychosis; depression; seizures; visual disturbance; drug abuse or dependence
Mixed salts of a single-entity amphetamine product (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate)Adderall®Adderall XR®Ages 6 and olderAdvanced arteriosclerosis; symptomatic cardiovascular disease; moderate-to-severe hypertension; hyperthyroidism; known hypersensitivity or idiosyncrasy to the sympathomimetic amines; glaucoma; history of drug abuse; MAOIsSudden death (avoid in patients with serious cardiacconditions); hypertension and other cardiovascular conditions; psychosis; depression; seizures; visual disturbance; drug abuse or dependence
Mydayis®Ages 13 and olderHypersensitivity to amphetamines; MAOIs.Sudden death (avoid in patients with serious cardiacconditions); hypertension and other cardiovascular conditions; psychosis; depression; seizures; visual disturbance; drug abuse or dependence.
Authors

10.3928/02793695-20200129-79

Sign up to receive

Journal E-contents